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Patients with chronic kidney disease (CKD) have increased
risk for cardiovascular events. However, the association
between these pathophysiological processes is unclear.
Therefore, this study was designed to determine the
association between early CKD and coronary microvascular
disease in patients with normal or mildly diseased coronary
arteries. A total of 605 patients with normal or mildly
diseased coronary arteries based on angiography underwent
coronary flow reserve (CFR) evaluation using intracoronary
adenosine. Patients were divided based on glomerular
filtration rate (GFR). CKD was defined as calculated
GFRo60 ml/min/1.73 m2. Patients with normal GFR (X60 ml/
min/1.73 m2, n¼ 481) had higher CFR compared to those
with CKD (n¼ 124, CFR¼ 3.070.8 vs 2.670.6, Po0.001,
respectively). Patients with abnormal GFR were more likely to
be older and of female gender, with greater prevalence of
hypertension. Multiple logistic regression analysis adjusted
for the aforementioned risk factors further supported the
observed relationship. The current study shows that reduced
renal function is associated with attenuated coronary
vasodilator capacity in patients without obstructive coronary
artery disease. The correlation between low GFR and reduced
CFR may suggest parallel alterations in the renal and
coronary microcirculation at the early stage of disease.
Impairment in both microcirculatory beds may reflect an
unmeasured risk factor induced by blunted renal function
and add a burden to the increased propensity for
cardiovascular events in CKD.
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Chronic kidney disease (CKD) is strongly associated with
increased risk of cardiovascular disease (CVD).1–4 The annual
mortality from CVD in dialysis patients is substantially
higher than in the general population.1,3 More than half of
the deaths in these patients are attributed to CVD.5
Furthermore, there is an emerging body of literature
suggesting that even mild renal disease is associated with
increased cardiovascular risk6–9 and adverse outcomes
(including progression to end-stage renal disease10), and
may be considered as an independent cardiovascular risk
factor.9,11 Impaired renal function is also associated with a
high prevalence of cardiovascular risk factors like hyperten-
sion and hypercholesterolemia, which may explain its
association with CVD.1,12–14 However, as elevated serum
creatinine has been a common exclusion criterion for most
cardiovascular studies, the data available on the association of
early renal dysfunction and CVD are relatively scant12,14,15
and the pathophysiological mechanism potentially mediating
this association is unclear.
Adequate myocardial16,17 and renal18 function depends on
the integrity of their microvascular beds, which regulate end
organ perfusion by vasodilation in response to increased
demand. The functional capacity of the myocardial micro-
circulation may be assessed by coronary flow reserve (CFR),
and glomerular filtration rate (GFR) may in part reflect and
rely on the integrity of the renal microvascular bed. We
hypothesized that microvascular dysfunction is a systemic
disorder that might cause parallel deleterious alterations in
both the coronary and the renal microvasculature at early
stages. Therefore, we sought to evaluate possible relationships
between coronary microvascular integrity, assessed by CFR,
and early renal dysfunction, assessed by GFR, in patients with
normal or mildly diseased coronary arteries.
RESULTS
Clinical characteristics
The patients included in this study (n¼ 605) were without
obstructive coronary artery disease (CAD), and were divided
by the presence of renal dysfunction, according to GFR. They
had either normal renal function (GFRX60 ml/min/1.73 m2,
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n¼ 481) or renal dysfunction (GFRo60 ml/min/1.73 m2,
n¼ 124). The patient characteristics grouped by GFR are
shown in Table 1. Patients with abnormal GFR were more
likely to be older and of female gender, with greater
prevalence of hypertension, and with a trend for greater
prevalence of dyslipidemia, but with similar body mass index.
Table 1 also shows no significant difference between the study
groups with respect to the prevalence of other traditional
cardiovascular and/or renal risk factors (i.e. diabetes,
smoking, and obesity). Left ventricular function was assessed
by ventriculography and was similar for both groups.
Comparison of coronary microvascular function stratified by
renal dysfunction
Patients with abnormal GFR had significantly lower CFR
than patients with normal GFR (Table 1 and Figure 1). The
presence of attenuated CFR was significantly higher
(Po0.001) in subjects with renal dysfunction than in those
with normal renal function (39 vs 23%, respectively).
Notably, the resistance base of coronary arteries (systemic
pressure divided by coronary blood flow, mmHg/ml/min)
was significantly greater in patients with renal dysfunction
(Table 1). The odds ratio (OR) for coronary microvascular
impairment was 2.14 (95% confidence interval 1.40–3.27) for
patients with renal dysfunction vs normal renal function
patients (Table 2).
Adjustment for other risk factors
Several risk factors were observed to be significantly
associated with reduced coronary microvascular function.
Age, female gender, mean arterial pressure, and history of
hypertension were all highly associated with low CFR
(Table 2). Body mass index and diabetes mellitus had a
trend for an association with low CFR. Current smoking
status and hyperlipidemia were not significantly associated
with attenuated CFR. Adjustment via multiple logistic
regression indicated that the observed association between
low GFR and CFR is due to one or more of these risk factors
(Table 3). The partial OR for low CFR is 1.36 (95%
Table 1 | Systemic characteristics, risk factors, and renal and
heart parameters (mean7s.d.) of normal and CKD patients,
grouped by GFR
Patient characteristics by GFR
Variable
GFRX60
(N=481)
GFRo60
(N=124) P-value
Age (years) 47.4711.8 58.9710.6 o0.001
Female, no. (%) 275 (57%) 100 (81%) o0.001
Hypertension, no. (%) 156 (33%) 56 (45%) 0.008
Diabetes, no. (%) 32 (7%) 8 (6%) 0.93
Hyperlipidemia, no. (%) 205 (43%) 64 (52%) 0.07
Current smoker, no. (%) 72 (15%) 13 (10%) 0.19
Body mass index (kg/m2) 28.475.9 28.475.6 1.00
Ejection fraction (%) 63.779.8 62.9710.5 0.56
Mean arterial pressure (mmHg) 101.1714.6 105.5715.5 0.003
Hemoglobin (g/dl) 13.571.4 13.171.2 0.007
Creatinine (mg/dl) 1.070.2 1.270.2 o0.001
Uric acid, serum (mg/dl) 5.271.5 5.871.7 0.030
Blood urea nitrogen (mg/dl) 13.774.4 17.276.1 o0.001
Glomerular filtration rate (ml/min) 76.1712.3 52.975.8 —
Glucose (mg/dl) 98.1724.7 99.5719.5 0.57
C-reactive protein, median (Q1, Q3) 0.4 (0.1, 0.4) 0.3 (0.1, 0.5) 0.89
Coronary arteries diameter (mm) 2.270.6 2.170.6 0.013
Coronary blood flow (ml/min) 51.8733.9 47.7729.6 0.23
Resistance base (mmHg/ml/min) 2.771.9 3.472.9 0.002
Max. coronary flow reserve 3.070.8 2.670.6 o0.001
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Figure 1 | Average CFR value (ratio) per GFR (ml/min/1.73 m2)
group. Mean and standard deviation are reported above each bar.
The P-value indicates a significant trend in mean CFR values over
increasing GFR levels.
Table 2 | Unadjusted odds ratios for coronary microvascular
disease
Risk factor
Odds
ratio
95% confidence
interval P-value
GFRo60 ml/min/1.73 m2) 2.14 1.40, 3.27 o0.001
Age (per 10 years) 1.43 1.22, 1.67 o0.001
Female gender 3.31 2.13, 5.14 o0.001
Body mass index (per 5 kg/m2) 0.85 0.73, 1.00 0.052
Hypertension 1.85 1.28, 2.68 0.001
MAP (per 10 mmHg) 1.23 1.09, 1.39 o0.001
Diabetes 1.85 0.95, 3.60 0.071
Current smoker 0.70 0.40, 1.23 0.21
Hyperlipidemia 1.15 0.80, 1.66 0.44
MAP: mean arterial pressure.
Table 3 | Multiple logistic regression model estimates for
coronary microvascular disease
Risk factor
Odds
ratio
95% confidence
interval P-value
GFRo60 ml/min/1.73 m2) 1.36 0.85, 2.20 0.20
Age (per 10 years) 1.21 1.01, 1.45 0.043
Female gender 2.70 1.70, 4.29 o0.001
Body mass index (per 5 kg/m2) 0.80 0.67, 0.96 0.017
Hypertension 1.62 1.05, 2.51 0.029
MAP (per 10 mmHg) 1.07 0.93, 1.23 0.32
Diabetes 1.76 0.85, 3.68 0.13
Current smoker 0.91 0.49, 1.68 0.76
Hyperlipidemia 0.94 0.61, 1.43 0.76
MAP: mean arterial pressure.
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confidence interval 0.85–2.20; P¼ 0.20) for patients with
renal dysfunction. Older age, female gender, hypertension,
and body mass index were all significantly associated with
decreased CFR after adjustment for other risk factors. Further
model analyses showed that the attenuation of the association
between renal dysfunction and reduced CFR is largely
explained by age and gender differences. After adjusting for
all risk factors except age and gender, the association is still
significant (OR 1.93; 95% confidence interval 1.25–2.99;
P¼ 0.003).
DISCUSSION
The principal finding of this study is the significant
association between early renal dysfunction and attenuated
CFR in patients with normal or mildly diseased coronary
arteries. Patients with worse renal function tend to be in the
lower limits of CFR. Thus, this study suggests that attenuated
CFR may potentially contribute to the increased cardiovas-
cular events in patients with CKD even in the absence of
obstructive CAD, likely reflecting impairment in the micro-
circulation of both vascular beds as a potential pathophysio-
logical mechanism.
Microcirculation abnormality as a systemic disorder
In common to other organs, renal and, coronary micro-
circulation supplies oxygen and nutrients and removes toxins
and metabolic end products from the surrounding tissues.19
Microvascular dysfunction appears to be part of a systemic
process,20,21 and similar histopathological changes in several
vascular beds including retinal,22,23 renal,24,25 and coronary
microcirculation26–28 may result in the occurrence of systemic
microcirculation abnormality, thereby resulting in renal
dysfunction as well as impairment of CFR. Importantly, the
existence of microvascular disease in a remote site (e.g. the
retina) has been shown to be independently associated with
cardiovascular mortality.23
Accumulating evidence supports the role of CKD as a
pronounced and independent risk factor for CVD, associated
with incident events.2,29–31 Reduced kidney function may be a
marker for both duration and severity of cardiovascular risk
factors such as hypertension.32 About 70–90% of individuals
with CKD have hypertension, and its prevalence increases as
GFR decreases.33,34 Arterial hypertension is associated with
the presence of systemic microvascular remodeling, char-
acterized by adaptive structural and functional changes in
small-resistance arteries35–39 and suggested as a prognostic
factor for cardiovascular events.40 A reduction in CFR may
play a role in the development of myocardial ischemia in
patients with arterial hypertension27 and normal coronary
arteries,28,41,42 and may be associated with increased
cardiovascular mortality.43 Therefore, the greater prevalence
of hypertension in the low-GFR group may have actively
contributed to the parallel early functional alterations in both
the renal and the coronary microcirculation suggested in this
study, supported by a strong association between renal
dysfunction and reduced CFR. Moreover, despite the higher
resistance base of the coronary vascular bed from patients
with lower GFR, the CFR in those patients remained lower,
which further supports the notion of a simultaneous
impairment in both microcirculatory beds. Notably, despite
being lower, the CFR in the renal dysfunction group was still
within normal limits, underscoring the early nature of this
impairment in cardiac microcirculation.
The current study shows that patients with early CKD
were more likely to be older and of female gender, and with
greater prevalence of hypertension. Furthermore, these
patients also have slightly reduced hemoglobin44 and
increased uric acid levels,45 likely reflecting an early
consequence of renal functional impairment. Thus, it is
possible that several concurrent factors may have been
involved in the parallel microvascular alterations hypothe-
sized in the current study. Our data suggest an inverse
relationship between age and mean arterial pressure, and the
functional capacity of both the coronary and renal micro-
vasculature beds assessed by CFR and GFR, respectively. In
addition, it also implies a role for age and female gender on
the concurrent effect on GFR and CFR impairment.
Simultaneous functional deterioration accompanied by
structural changes in several microcirculatory beds with age
progression has been described elsewhere,46–48 supporting the
notion of this process as a systemic disorder. Notably, the
dilator capacity of the coronary circulation is well maintained
over a wide range of ages. However, because of an age-related
increase in cardiac work and consequently myocardial blood
flow at rest,49 the myocardial blood flow reserve declines with
age.50 In addition, early markers suggestive of renal
dysfunction (e.g. elevated serum creatinine, borderline
decreased GFR) are more frequent in older adults and are
associated with increased risk of CVD, heart failure, and all-
cause mortality.9,51 This increased risk in the elderly
population is apparent early in renal disease, and linearly
progresses as creatinine increases.9 On the other hand, the
contribution of gender to the observed risk may be related to
the observation that coronary microvascular dysfunction is
present in approximately one half of women with chest pain,
even in the absence of obstructive coronary disease.52 Indeed,
more women than men have chest pain without significant
CAD.52 The current study focused on patients without
obstructive CAD and it is possible that more men at this stage
have evident CAD, which were the main exclusion criteria of
our study. The greater prevalence of evident CAD in aging
men compared to women may reflect the natural history of
coronary atherosclerosis and also the previous observations
that women, in general, have a higher incidence of small-
vessel disease, which may be reflected in coronary and renal
circulation. CKD is an independent predictor for overt
coronary disease in women, and even mildly increased serum
creatinine is probably a marker for unmeasured pro-
atherogenic factors involved in CVD morbidity and mortality
in females.7 Similarly, the slightly diminished hemoglobin
levels observed in these patients could also be considered as
an additional cardiovascular risk factor among the lower GFR
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population.53,54 In addition, the higher (although within the
normal limits) serum uric acid in the lower GFR group may
have also contributed to the comparable microcirculatory
functional impairment suggested in the current study,
possibly via decreasing nitric oxide availability, and favoring
microvascular inflammation and sclerosis.45
Thus, the extent of impaired microvascular functional
capacity in one vascular bed may be related to the concurrent
impairment of functional capacity in another microvascular
bed, which may certainly have been aggravated by age and
female gender in the current study. Although the correlation
between age, gender, hypertension, and CFR is well known
from the literature, the notion of a systemic microvascular
alteration suggested in this study constitutes a novel finding.
Indeed, the association between early renal dysfunction and
attenuated coronary vasodilator reserve may reflect an
unmeasured risk factor induced by blunted renal function,
which causes CVD, or may be an outcome of an underlying
pathological process that affects both GFR and CFR.
Potential limitations
The current study was conducted in patients undergoing
coronary angiography and, thus, a selection bias cannot be
ruled out. The decision to refer the patient for cardiac
catheterization was at the discretion of the attending
cardiologist; therefore, it is possible that physicians were less
likely to undertake cardiac catheterization in patients with
known renal dysfunction, because of increased risk. Conse-
quently, a potentially higher ‘threshold’ for catheterizing
patients with parameters suggestive of renal dysfunction (e.g.
high creatinine levels) cannot be excluded.
Conclusions and clinical implications
Our study shows a strong association between low GFR and
attenuated CFR in patients without evidence of CAD.
Patients with renal dysfunction exhibit a reduced coronary
vasodilator capacity that may represent a simultaneous
alteration in the microcirculation of both systems that might
be elicited by the same traditional cardiovascular risk factors.
This study further supports the concept of a differential effect
of gender and risk factors such as hypertension on the
development of atherosclerosis and microvascular disease.
Furthermore, renal risk stratification of patients with early
coronary atherosclerosis and normal or mildly diseased
coronary arteries may identify groups with increased risk
for coronary microvascular disease (above the risk provided
by the conventional risk factors) that might be translated to
an increased risk for cardiovascular events. The current study
underscores the need to address microvascular disease as a
systemic condition that might affect coronary and renal
microvasculature in a similar manner.
MATERIALS AND METHODS
Study population
In this study, 605 consecutive patients who had been referred for
cardiac catheterization to exclude CAD were examined. The decision
to refer the patient for cardiac catheterization was at the discretion
of the attending cardiologist. Patients were included in this study if
they had all the following characteristics: (1) angiographically
smooth arteries, (2) mild irregularities with no coronary artery
lesion 430% lumen diameter stenosis by visual assessment in any
major epicardial vessel, and (3) proximal coronary arteries
42.0 mm in diameter. Exclusion criteria included an obvious
history of variant angina, acute coronary syndromes, previous
myocardial infarction (o6 months), and previous coronary artery
bypass graft or coronary intervention.55 Patients on dialysis were not
included in this study. To allow the assessment of coronary
physiology at baseline, long-acting nitrates, angiotensin-converting
enzyme inhibitors, and calcium channel-blocking agents were
withheld for at least 48 h before the study. The Mayo Clinic
Institutional Review Board approved the study and informed
consent was obtained.
The patients were subsequently divided into two groups
according to their renal function, as assessed by estimated GFR at
the time of the study. Group 1 included patients with normal renal
function (GFRX60 ml/min/1.73 m2) and group 2 included patients
with impaired renal function (GFRo60 ml/min/1.73 m2).
Assessment of renal function
The assessment of renal function was based on the estimated GFR
equation from the modified MDRD (modification of diet in renal
disease): GFR (ml/min/1.73 m2)¼ 186(SCr)1.154(Age)0.203(0.742 if
female)(1.210 if black).2 The presence or absence of abnormal renal
function was defined by using the cutoff of 60 ml/min/1.73 m2 as the
lower limit of GFR for normal renal function.2,29,56
Study protocol and determination of CFR
Diagnostic coronary angiography was performed using a 6F Judkins
catheter with a standard femoral percutaneous approach. Heparin
(2500 U) was administered intravenously at the beginning of the
procedure. Nonionic contrast material was used for all patients. To
study coronary vascular reactivity response to adenosine, a 0.014-
inch Doppler guide wire (Volcano, Rancho Cordova, CA, USA) was
advanced through a coronary guiding catheter engaged in the left
main coronary artery and positioned in the mid-portion of the
left anterior descending coronary artery.55 Mean arterial pressure
and heart rate were continuously monitored. Baseline average
peak velocity was recorded. Next, intracoronary bolus injections of
18–60 mg of adenosine were administered into the guiding catheter
until maximal hyperemia was achieved. Maximal average peak
velocity was recorded. CFR was calculated as the ratio of the
averaged peak velocity at maximal hyperemia to baseline velocity.55
Coronary microvascular dysfunction was defined as CFRo2.5,
which is widely accepted as the lower limit of normal flow reserve in
arteries free of significant epicardial obstructive disease.16,17,57,58
Statistical analysis
Data for continuous variables are presented as the mean7s.d.,
unless indicated otherwise. Discrete variables are presented as
frequencies and percentages of available data. Differences between
groups were tested by Student’s t-test or Pearson’s w2 test, as
appropriate. Logistic regression was employed to calculate ORs and
their 95% confidence intervals. The association between renal
dysfunction and coronary microvascular disease after adjusting for
conventional risk factors (age, gender, history of hypertension, mean
arterial pressure, diabetes, body mass index, hyperlipidemia, and
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smoking) is summarized as an OR estimated by multiple logistic
regression. As estimated GFR is related to age and gender by its
calculation, adjustments for only age and gender and excluding age
and gender were also considered. A value of Po0.05 was considered
statistically significant; all tests were two-tailed. All analyses were
performed using SAS version 8.2 software (SAS Inc., Cary, NC, USA).
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